Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation
Clinical trial NCT07626281 · RECRUITING
Trial details
- NCT number
- NCT07626281
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-09
- Primary completion
- 2026-12-21
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.